Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Hutter

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Blood|October 18, 2012
Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cellsCaroline Hutter, Max Kauer, Ingrid Simonitsch-Klupp, et al.
Cancer Medicine|July 4, 2019
PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categoriesAna-Iris Schiefer, Elisabeth Salzer, Anna Füreder, et al.
Klinische Padiatrie|September 4, 2023
[Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents]Thomas Lehrnbecher, Martina Ahlmann, Michael Albert, et al.
Blood|December 4, 2024
BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responsesGiulio Abagnale, Raphaela Schwentner, Philipp Ben Soussia-Weiss, et al.
Cancer Discovery|July 27, 2019
Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell HistiocytosisFlorian Halbritter, Matthias Farlik, Raphaela Schwentner, et al.
Haematologica|October 15, 2020
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulationMarini Thian, Birgit Hoeger, Anton Kamnev, et al.
JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Nature Communications|May 29, 2021
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burdenPeter Peneder, Adrian M Stütz, Didier Surdez, et al.
Nature Medicine|January 31, 2017
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcomaNathan C Sheffield, Gaelle Pierron, Johanna Klughammer, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Blood|October 18, 2012
Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cellsCaroline Hutter, Max Kauer, Ingrid Simonitsch-Klupp, et al.
Cancer Medicine|July 4, 2019
PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categoriesAna-Iris Schiefer, Elisabeth Salzer, Anna Füreder, et al.
Klinische Padiatrie|September 4, 2023
[Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents]Thomas Lehrnbecher, Martina Ahlmann, Michael Albert, et al.
Blood|December 4, 2024
BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responsesGiulio Abagnale, Raphaela Schwentner, Philipp Ben Soussia-Weiss, et al.
Cancer Discovery|July 27, 2019
Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell HistiocytosisFlorian Halbritter, Matthias Farlik, Raphaela Schwentner, et al.
Haematologica|October 15, 2020
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulationMarini Thian, Birgit Hoeger, Anton Kamnev, et al.
JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Nature Communications|May 29, 2021
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burdenPeter Peneder, Adrian M Stütz, Didier Surdez, et al.
Nature Medicine|January 31, 2017
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcomaNathan C Sheffield, Gaelle Pierron, Johanna Klughammer, et al.
Pageof 4